Healum

Patients

The primary care setting has garnered significant attention from industry stakeholders due to its promise in commercial research.

News

Roche has staked a claim to the increasingly crowded IgAN market with an accelerated approval from the FDA for Ultomiris, its fifth indication.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.